Evaluation of the company price cannot be placed upon the

New Post Public Reply Private Reply Replies (1) Message Board
NickAidenNY
413
Evaluation of the company price cannot be placed upon the market or share price at this point. It’s obvious that retail investors are not parting with their shares and Aspire doesn’t hold enough for a large Pharma to gain any sort of control; and if they purchase on the open market it would send this thing sky rocketing anyway. Large Pharma is not depressing the price, as some say, so this can go BK; they would be bidding against any and all participants looking for the assets as a foreclosed home hits the county steps. It’s not Big Pharma’s game and it’s not what’s happening here. They will pay for what the assets are worth and they have people whom have spent their whole lives and education to make that determination, not IHub posters.

MMs are manipulating bid and ask as they see volume come in or leave. The natural cycle of this stock will not allow this to occur much longer...

If you have money that you can “play” with, then my opinion is to gobble up as much as possible as close to $.40 as you can but don’t let the MM’s walk this up on you. Buy wisely and let them sweat till news. It is coming...


Misrepresentations and revilement have completely taken over this board but one must assume this is what will occur when silence is the only voice to consider.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Gaby Natale to Inspire at Procter & Gamble's LatinOvation

Updated Category News Views 189

Gaby Natale to Motivate at Procter & Gamble's LatinOvation Gaby Natale, a celebrated triple Emmy award-winning journalist and bestselling author, is poised to deliver the impactful closing keynote at Procter & Gamble's annual LatinOvation event. This year, the gathering continues to honor the substantial contributions from the Hispanic community, rallying around the theme...

Continue Reading
GitLab's Market Resilience and Adjustments in Earnings Outlook

Updated Category News Views 124

GitLab's Steady Growth Amid Price Forecast Adjustments In recent developments, analyst Pinjalim Bora from JP Morgan has reiterated a Neutral rating on GitLab Inc. (NASDAQ: GTLB), adjusting the price forecast from $65 down to $62. Quarterly Performance Shines GitLab’s recent quarterly earnings report revealed surprising strength, with the company posting earnings of 33...

Continue Reading
Understanding Recent Trading Trends for Exxon Mobil Options

Updated Category News Views 73

Insights into Exxon Mobil Options Trading Recent analysis highlights a bullish trend in Exxon Mobil's trading activity. Our examination of the stock, identified by the symbol XOM, has uncovered significant patterns in the options market. Our investigation into the history of options trading shows that 53% of traders are leaning towards a bullish outlook, while 33% have a...

Continue Reading
Ming Tsai Launches Exciting New Frozen Meals Across Stores

Updated Category News Views 519

Ming Tsai Launches Exciting New Frozen Meals Nationwide Ming Tsai, an acclaimed chef known for his innovative culinary skills, has recently introduced a new line of products called Mings™ frozen meals. This line aims to transport your taste buds across Asia with authentic flavors that can now be found in Walmart stores across the country. A Culinary Adventure Awaits...

Continue Reading
Truist Financial Corporation Insights on Q3 2024 Performance

Updated Category News Views 237

Truist Financial Corporation Reports Strong Q3 2024 Results Truist Financial Corporation (NYSE: TFC) released its results for the third quarter of 2024 today, showcasing its fiscal health and commitment to enhancing customer experience. The company continues to focus on delivering robust financial performance while engaging its client base and broader community. Key...

Continue Reading